Clinical Trial Update: A Trial of Cabazitaxel for Advanced Transitional Cell Carcinoma (TCC) [Phase 2]

View source ↗

Summary

Completed Phase 2 clinical trial evaluating cabazitaxel for advanced urothelial carcinoma (transitional cell carcinoma).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• Cabazitaxel (cabazitaxel)

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Urothelial Carcinoma | Phase 2 | Status: COMPLETED